contactenos@vnovamed.com.co

Myosop®

REGISTRO SANITARIO INVIMA: SD2022-0004665

OBSERVACIONES:
ESTE PRODUCTO, ES UN SUPLEMENTO DIETARIO, NO ES UN MEDICAMENTO Y NO SUPLE UNA ALIMENTACIÓN EQUILIBRADA.

INDICACIONES:
SUPLEMENTO DIETARIO

PRINCIPIO ACTIVO:
MIOINOSITOL, ÁCIDO FÓLICO, VITAMINA D, YODO, ZINC

PRESENTACIÓN:
CAJA CONTENIENDO 30 SOBRES EN LAMINADO (POLIESTER ALUMINIO/POLIETILENO), CADA SOBRE POR 4 GRAMOS DE POLVO

BIBLIOGRAFÍA:

  1. Gambioli R, Forte G, Buzzaccarini G, Unfer V, Laganà AS. Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation. Pharmaceuticals (Basel). 2021 May 25;14(6):504. doi: 10.3390/ph14060504. PMID: 34070701; PMCID: PMC8227031.
  2. Ulloa-Aguirre A., Reiter E., Crépieux P. FSH Receptor Signaling: Complexity of Interactions and Signal Diversity. 2018; 159:3020–3035. doi: 10.1210/en.2018-00452.
  3. Casarini L., Santi D., Brigante G., Simoni M. Two hormones for one receptor: Evolution, biochemistry, actions, and pathophysiology of LH and hCG. Rev. 2018; 39:549–592. doi: 10.1210/er.2018-00065.
  4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum. 2004; 19:41–47. doi: 10.1093/humrep/deh098.
  5. Costantino D., Minozzi G., Minozzi E., Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: A double-blind trial. Rev. Med. Pharm. Sci. 2009; 13:105–110.
  6. Papaleo E., Unfer V., Baillargeon J.P., de Santis L., Fusi F., Brigante C., Marelli G., Cino I., Redaelli A., Ferrari A. Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction. Gynecol. Endocrinol. 2007; 23:700–703. doi: 10.1080/09513590701672405.
  7. U-Allah I., Sabeen N., Iqbal Q., Zulfiqar S., Wasim T. Myoinositol in restoring spontaneous ovarian activity in patients with polycystic ovarian syndrome (PCOS) Esculapio. 2020; 16:41–45. doi: 10.51273/esc20.2516310.
  8. Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y. Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine (Baltimore). 2017 Dec;96(49): e8842. doi: 10.1097/MD.0000000000008842. PMID: 29245250; PMCID: PMC5728865.